4//SEC Filing
Aftab Dana 4
Accession 0000939767-24-000157
CIK 0000939767other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 7:44 PM ET
Size
9.7 KB
Accession
0000939767-24-000157
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Aftab Dana
EVP, Research and Development
Transactions
- Exercise/Conversion
Common Stock
2024-11-05$18.80/sh+96,986$1,823,337→ 595,931 total - Exercise/Conversion
Option (right to buy)
2024-11-05−96,986→ 0 totalExercise: $18.80From: 2019-09-10Exp: 2025-09-09→ Common Stock (96,986 underlying) - Sale
Common Stock
2024-11-05$35.00/sh−96,986$3,394,510→ 498,945 total
Holdings
- 5,835(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Includes 288,932 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023.
- [F3]Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 4, 2024.
- [F4]The option, representing the right to purchase a total of 96,986 shares of Common Stock, became fully exercisable on September 10, 2022.
Documents
Issuer
EXELIXIS, INC.
CIK 0000939767
Entity typeother
Related Parties
1- filerCIK 0001959132
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 7:44 PM ET
- Size
- 9.7 KB